Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Good news for older colorectal cancer patients: quality of life largely holds steady after curative treatment. A Dutch study of 122 patients aged 70+ found that while physical functioning dipped slightly at 3 months post-treatment, it never reached a clinically meaningful decline. Over 12 months, overall quality of life remained stable — a reassuring signal for treating metastatic disease in older adults.
Treating metastatic colorectal cancer with curative intent in older patients doesn't have to mean sacrificing quality of life. A new Dutch study tracking 122 patients aged 70 and older found that quality of life (QOL) remained stable over 12 months following local surgical or ablative therapy for metastases — offering meaningful reassurance for clinicians weighing treatment options in this population.
Physical functioning did dip at the 3-month mark, but the decline never crossed the threshold for clinical significance. By 6 and 12 months, scores were slightly below baseline but still not meaningfully different. The liver was the most common metastatic site (67%), and most patients had disease limited to a single site.
By the Numbers:
Why it matters: These findings support offering curative local treatment to older patients with metastatic colorectal cancer — a group often undertreated due to age-related concerns. However, individual monitoring remains essential, as a meaningful subset does experience significant functional decline.
